喜悦小猫咪
Lv41
432 积分
2023-07-03 加入
-
Predicting and overcoming poor patient responses to sublingual immunotherapy for allergic diseases
9天前
已完结
-
Immune mechanisms of allergen‐specific sublingual immunotherapy
9天前
已完结
-
Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite–induced allergic rhinitis
1个月前
已完结
-
Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial
1个月前
已关闭
-
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
1个月前
已完结
-
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
1个月前
已关闭
-
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
1个月前
已完结
-
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
1个月前
已完结
-
支气管哮喘防治指南(2024年版)
2个月前
已完结
-
Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3+ regulatory T cells
3个月前
已完结